Shares of BriaCell Therapeutics Corp. (CVE:BCT – Get Free Report) were down 3.8% during mid-day trading on Tuesday. The stock traded as low as C$10.60 and last traded at C$10.60. Approximately 3,402 shares changed hands during trading, a decline of 73% from the average daily volume of 12,671 shares. The stock had previously closed at C$11.02.
BriaCell Therapeutics Stock Performance
The company has a debt-to-equity ratio of 0.05, a current ratio of 129.63 and a quick ratio of 128.68. The stock has a 50-day simple moving average of C$10.60 and a 200 day simple moving average of C$10.60. The company has a market capitalization of C$168.68 million and a PE ratio of -28.19.
BriaCell Therapeutics Company Profile
Featured Articles
- Five stocks we like better than BriaCell Therapeutics
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
